RINACARE LTD

Company Registration Number:
12106987 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

RINACARE LTD

Contents of the Financial Statements

for the Period Ended 31 July 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

RINACARE LTD

Company Information

for the Period Ended 31 July 2024




Director: C O MADU
Registered office: 130
Becton Place
London
GBR
DA8 1JW
Company Registration Number: 12106987 (England and Wales)

RINACARE LTD

Directors' Report Period Ended 31 July 2024

The directors present their report with the financial statements of the company for the period ended 31 July 2024

Directors

The director(s) shown below were appointed to the company during the period
C O MADU
01 August 2023

This report was approved by the board of directors on 28 January 2025
And Signed On Behalf Of The Board By:

Name: C O MADU
Status: Director

RINACARE LTD

Profit and Loss Account

for the Period Ended 31 July 2024


Notes

2024
£

2023
£
Turnover 0 16,812
Cost of sales ( 0 ) ( 14,500 )
Gross Profit or (Loss) 0 2,312
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 0 ) ( 2,400 )
Other operating income 0 0
Operating Profit or (Loss) 0 ( 88 )
Interest Receivable and Similar Income 0 0
Interest Payable and Similar Charges ( 0 ) ( 0 )
Profit or (Loss) Before Tax 0 ( 88 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period 0 ( 88 )

The notes form part of these financial statements

RINACARE LTD

Balance sheet

As at 31 July 2024


Notes

2024
£

2023
£
Fixed assets
Intangible assets: 4 0 0
Tangible assets: 5 800 800
Total fixed assets: 800 800
Current assets
Stocks: 2,500 2,500
Debtors: 6 0 0
Cash at bank and in hand: 0 0
Total current assets: 2,500 2,500
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 7 ( 1,200 ) ( 1,200 )
Net current assets (liabilities): 1,300 1,300
Total assets less current liabilities: 2,100 2,100
Creditors: amounts falling due after more than one year: 8 ( 1,200 ) ( 1,200 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 900 900

The notes form part of these financial statements

RINACARE LTD

Balance sheet continued

As at 31 July 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 1 1
Revaluation reserve: 9 0 0
Profit and loss account: 899 899
Shareholders funds: 900 900

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 28 January 2025
And Signed On Behalf Of The Board By:

Name: C O MADU
Status: Director

The notes form part of these financial statements

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 1 1

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 3. Off balance sheet disclosure

    No

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Intangible assets

Other Total
Cost £ £
At 01 August 2023 0 0
Additions 0 0
Disposals ( 0 ) ( 0 )
Revaluations 0 0
Transfers 0 0
At 31 July 2024 0 0
Amortisation
Amortisation at 01 August 2023 0 0
Charge for year 0 0
On disposals ( 0 ) ( 0 )
Other adjustments 0 0
Amortisation at 31 July 2024 0 0
Net book value
Net book value at 31 July 2024 0 0
Net book value at 31 July 2023 0 0

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

5. Tangible assets

Plant & machinery Office equipment Motor vehicles Total
Cost £ £ £ £
At 01 August 2023 800 0 0 800
Additions 0 0 0 0
Disposals ( 0 ) ( 0 ) ( 0 ) ( 0 )
Revaluations 0 0 0 0
Transfers 0 0 0 0
At 31 July 2024 800 0 0 800
Depreciation
At 01 August 2023 0 0 0 0
Charge for year 0 0 0 0
On disposals ( 0 ) ( 0 ) ( 0 ) ( 0 )
Other adjustments 0 0 0 0
At 31 July 2024 0 0 0 0
Net book value
At 31 July 2024 800 0 0 800
At 31 July 2023 800 0 0 800

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

6. Debtors


2024
£

2023
£
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 0 0
Total 0 0
Debtors due after more than one year: 0 0

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

7.Creditors: amounts falling due within one year note


2024
£

2023
£
Bank loans and overdrafts 200 800
Amounts due under finance leases and hire purchase contracts 200 50
Trade creditors 200 50
Taxation and social security 200 100
Accruals and deferred income 200 100
Other creditors 200 100
Total 1,200 1,200

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

8.Creditors: amounts falling due after more than one year


2024
£

2023
£
Bank loans and overdrafts 200 200
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 1,000 1,000
Total 1,200 1,200

RINACARE LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

9. Revaluation reserve


2024
£
Balance at 01 August 2023 0
Surplus or deficit after revaluation 0
Balance at 31 July 2024 0